Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors (NETs): a pooled analysis from the randomized, phase 3 RADIANT-3 and RADIANT-4 trials.
Fazio, N Carnaghi, C Buzzoni, R Herbst, F Ridolfi, A Strosberg, J Kulke, M Pavel, M Yao, J
Fazio, N
Carnaghi, C
Buzzoni, R
Herbst, F
Ridolfi, A
Strosberg, J
Kulke, M
Pavel, M
Yao, J
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2018
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors (NETs): a pooled analysis from the randomized, phase 3 RADIANT-3 and RADIANT-4 trials. 2018, 211: Neuroendocrinology